Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Dec;31(6):1383-1393.
doi: 10.1002/jgc4.1613. Epub 2022 Aug 5.

The goldilocks conundrum: Disclosing discrimination risks in informed consent

Anya E R Prince  1 , Sonia M Suter  2 , Wendy R Uhlmann  3   4 , Aaron M Scherer  5
Affiliations
Randomized Controlled Trial

The goldilocks conundrum: Disclosing discrimination risks in informed consent

Anya E R Prince et al. J Genet Couns. 2022 Dec.

Abstract

Informed consent is a foundational ethical and legal principle in human subjects research and clinical care. Yet, there is extensive debate over how much information must be disclosed to meet ethical goals and legal requirements, especially about non-medical risks. In this online, survey-based experiment of a diverse sample of the US general population, we explored one aspect of this debate by testing whether the level of detail included in informed consent regarding genetic anti-discrimination protections alters individuals' willingness to participate in a hypothetical research study and their concerns regarding genetic discrimination. Participants were randomized to receive sample informed consent language with one of three levels of disclosure regarding the protections and limitations of the Genetic Information Nondiscrimination Act (GINA). Our sample (n = 1,195) had a mean age of 45.9 (SD = 17.9) years and 40% with ≤high school education. Participants were 51.3% female and 36.7% non-Hispanic White. On average, those who received consent language with none of GINA's limitations highlighted were more willing to participate than those who were warned about various gaps in GINA. They also had significantly lower perceived risk of discrimination than those presented with the most information about limitations. Our study found that providing more comprehensive information about GINA notably lessened willingness to participate in the hypothetical studies, highlighting the need for clinicians and researchers to thoughtfully consider how to disclose anti-discrimination risks in informed consent.

Keywords: Genetic Information Nondiscrimination Act; discrimination; genetic research; genetic testing; informed consent.

PubMed Disclaimer

Conflict of interest statement

AERP declares that she has no conflict of interest. SMS declares that she has no conflict of interest. WRU declares that she has no conflict of interest. AMS declares that he has no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Consent randomization
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Allain, D. C. , Friedman, S. , & Senter, L. (2012). Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act. Familial Cancer, 11, 637–644. - PubMed
    1. Amendola, L. M. , Robinson, J. O. , Hart, R. , Biswas, S. , Lee, K. , Bernhardt, B. A. , East, K. , Gilmore, M. J. , Kauffman, T. L. , Lewis, K. L. , Roche, M. , Scollon, S. , Wynn, J. , & Blout, C. (2018). Why patients decline genomic sequencing studies: Experiences from the CSER Consortium. Journal of Genetic Counseling, 27, 1220–1227. - PMC - PubMed
    1. Anderson, J. , Lewis, A. C. F. , & Prince, A. E. R. (2021). The problems with patchwork: State approaches to regulating insurer use of genetic information. DePaul Journal of Health Care Law, 22, 1–40.
    1. Areheart, B. A. , & Roberts, J. L. (2019). GINA, big data, and the future of employee privacy. Yale Law Journal, 128, 710–790.
    1. Barlow‐Stewart, K. , Liepins, M. , Doble, A. , & Otlowski, M. (2018). How are genetic test results being used by Australian life insurers? European Journal of Human Genetics, 1, 1248–1256. - PMC - PubMed

Publication types